Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Efficacy and Safety of Relaxin for the Treatment of Acute Heart Failure (RELAX-AHF)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Corthera, Inc.(formerly BAS Medical, Inc.), a member of the Novartis group of companies
ClinicalTrials.gov Identifier:
NCT00520806
First received: August 24, 2007
Last updated: October 26, 2012
Last verified: May 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2012
  Primary Completion Date: September 2012 (Final data collection date for primary outcome measure)
No publications provided by Corthera, Inc.(formerly BAS Medical, Inc.), a member of the Novartis group of companies

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):